GRTX — Galera Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Galera Therapeutics - On May 30, Filed A Lawsuit Against Alira Health Clinical, Llc And Iqvia Biotech, Llc Alleging Breach Of Contract And Negligence
Brief: Galera Announces FDA Orphan Drug Designation Granted To Rucosopasem For Pancreatic Cancer
Galera Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Galera Reports Q1 2023 Financial Results And Recent Corporate Updates
H.C. Wainwright cuts Galera's PT after stock sale
Brief: Galera To Present Supplemental Analysis Of Phase 3 Trial At European Congress On Head And Neck Oncology
Galera Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Galera Reports Fourth Quarter And 2022 Financial Results
Galera Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Galera Therapeutics Inc Files For Offering Of Up To 14.32 Million Shares Of Common Stock - SEC Filing
U.S. STOCKS ON THE MOVE-Bank of America, Silvergate Capital, Energy firms
U.S. STOCKS ON THE MOVE-Lithia Motors, Sera Prognostics, Citigroup
Galera Therapeutics rises on FDA's priority review for oral mucositis drug
Brief: Galera Therapeutics - Expects To Report Co Had Cash And Cash Equivalents & Short-Term Investments Of About $31.6 Million As Of December 31, 2022
Brief: Galera Announces FDA Acceptance And Priority Review Of Avasopasem NDA
Brief: Galera Therapeutics Co Received Letter From Nasdaq Stating That Co Had Regained Compliance
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
Brief: Galera Submits Marketing Application For Oral Mucositis Drug
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber